Xofluza

Medicinal product

(Invented) name

Xofluza

Active substance (s)

Baloksaviras marboksilas

Strength

20 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J05AX25, baloxavir marboxil

Marketing authorisation holder

Roche Registration GmbH, Vokietija

Date of authorisation

2021-01-07

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Film-coated tablet	1 vnt.
Baloksaviras marboksilas	20 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
105636	91736	1091736	lizdinė plokštelė	N2		Receptinis	EU/1/20/1500/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2021-01-07	Registruotas